| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3d11eae8c84c5d7a715d1c76803b3cc9 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08G65-337
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08G65-332
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08G65-325
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08G65-33348
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-593
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-595
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5575 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-59
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02 |
| filingDate |
2018-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e3d3621b80a62e49dfa868c0bed85c22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2dc74778777e80acf2f2c4432f411a71
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_975ed8de352d5307d0f7fccdda2fdaa4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_53f0823ec3c646f95920c2006431f398
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5b3ca309572b807d817d273b1ee1222f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a72a5cb25bad4cc303d9fcececdff340
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4b0dd2ff2ae435575f1e7a0df4c244e7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_155e0a296d43d3f65cfef85b19ebef49
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b8c34fb1d2bf03e14b953cb57b8c58f5 |
| publicationDate |
2020-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2020121798-A1 |
| titleOfInvention |
Drug-polymer conjugate |
| abstract |
A polymer-prostaglandin conjugate comprising: a polymer backbone comprising a plurality of moieties of formula (I): where: T represents a triazole moiety; Q is independently selected at each occurrence and may be present or absent and when present represents a linking group; R is selected from the group consisting of linear or branched hydrocarbon; D is selected from prostaglandins; and L is a group of formula (II) wherein R 5 is selected from hydrogen and C 1 to C 6 alkyl; (R) indicates the end of the group bonded to the R group; and (D) indicates the end of the group attached to the group D. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11787906-B2 |
| priorityDate |
2013-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |